Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • VeenaV
    Junior Member
    • Jul 2010
    • 4

    MACS peaks

    Hi,

    Am using MACS for the first time. I ran MACS on my sequence data and I find peaks (as listed in the bed file) in regions that have no signal. Why would this be? Has anyone encountered this phenomenon before? Please suggest.

    Thanks in advance,
    Veena
  • dawe
    Senior Member
    • Apr 2009
    • 258

    #2
    Originally posted by VeenaV View Post
    Hi,

    Am using MACS for the first time. I ran MACS on my sequence data and I find peaks (as listed in the bed file) in regions that have no signal. Why would this be? Has anyone encountered this phenomenon before? Please suggest.

    Thanks in advance,
    Veena
    How did you check there's no signal in those regions?

    Comment

    • VeenaV
      Junior Member
      • Jul 2010
      • 4

      #3
      hi Dawe, All,

      I debugged the issue and found that it was basically an issue with the input file fed to MACS.
      I was running MACS on .sam files. The program used to generate signal
      files from .sam files excluded repeats (X:A:R tags), whereas MACS
      included the repeats in the .sam file. I now reran MACS using the bed
      files as input for MACS (instead of .sam files) and it looks fine
      now.

      Thanks,
      Veena

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      15 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      15 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      37 views
      0 reactions
      Last Post SEQadmin2  
      Working...